Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Implementing International Standards of Practice in A Low Resource Country by Blended Training Modules to Improve Stroke Care

2 augusti 2021 uppdaterad av: Foundation University Islamabad
Lack of proper stroke care delivery leads to poor patient outcomes in middle- and low-income countries that can be improved by implementation of international standards. We aim to determine feasibility of implementing stroke core measures and training through blended learning modules in resource poor countries to improve stroke outcomes.

Studieöversikt

Status

Aktiv, inte rekryterande

Betingelser

Detaljerad beskrivning

Background: Lack of proper stroke care delivery leads to poor patient outcomes in middle- and low-income countries that can be improved by implementation of international standards. We aim to determine feasibility of implementing stroke core measures and training through blended learning modules in resource poor countries to improve stroke outcomes.

Methods: The project will be conducted across four hospitals in Pakistan in three phases. First stage will include retrospective collection of data for the preceding 4 weeks from start. In stage II, 3 months data will be collected before implementation of core measures. The stepwise training of staff will begin simultaneously, and data will continue to be collected. In stage III by the end of 3 months of stage II, core measures will be implemented as standard of care and patients will be enrolled for another 3 months. Outcomes measures will be successful implementation of the stroke care model as measured by survey done at the end and patient outcomes including in-hospital complication rates, length of hospital stay, patient and caregiver education, mRS at 3 months after discharge, post discharge complications and re-stroke rate. Data will be compared against published data from Pakistan and between patients in the first and last 3 months of the project. Statistical analyses will include appropriate mixed-effects multivariate regression models (i.e., linear and logistic) to model the relationship between clinical measures and patient safety. Degree of correlation across each symptom predictor will be measured. This study will not involve thrombolytic therapy or thrombectomy. However, the study will not provide any hindrance to implementation of such therapy and will not include such patients in analysis.

Discussion: At least one third of stroke survivors in Pakistan die due to recurrent vascular events and complications of stroke in absence of core measures. Prevention practices and stroke care are significantly underutilized in low- and middle-income countries but can be improved most efficiently by improving care delivering process without additional burden on resources by following American Heart Association "Get With The Guidelines" Stroke (GWTG-Stroke) program, Royal College of Physicians UK and European Guidelines, regardless of thrombolysis or thrombectomy. This feasibility study aims to develop a multidisciplinary comprehensive stroke team model with gradual integration of staff training, nursing care, therapy and patient education.

Studietyp

Observationell

Inskrivning (Faktisk)

100

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Fauji Foundation Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 80 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Patients presenting with acute stroke symptoms as deemed by treating physicians presenting to the ED will be enrolled. Normative data from the general population will be used where needed for comparison.

Beskrivning

Inclusion Criteria:

Acute onset of Symptoms in the last 24 hours suggestive of stroke Age > 18 years Ischemic or hemorrhagic stroke

-

Exclusion Criteria:

Presenting after 24 hours of onset of symptoms Alternate explanation for presenting symptoms (stroke mimics) Family (Surrogate Decision Maker) or next of kin/ patient refusal for participation Transfer of care from another department or hospital Care needed in another department (e.g, ICU, other department) GCS (Glasgow Coma Scale) below 5 or End of life care initiated TIA (Transient Ischemic Attack)

-

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Retrospective 3 months cohort (admitted stroke patients)
  1. Extracranial imaging
  2. ECG in 2-7 days
  3. DVT prophylaxis
  4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
  5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
  6. Fasting lipid profile, HbA1c
  7. Holter monitor
  8. Specialized workup for young stroke
  9. PFO Study, MES Study
  10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
  11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
  12. Follow-up plan and 90 day mRS
Prospective pre-implementation "standard of core care quality measures" cohort
  1. Extracranial imaging
  2. ECG in 2-7 days
  3. DVT prophylaxis
  4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
  5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
  6. Fasting lipid profile, HbA1c
  7. Holter monitor
  8. Specialized workup for young stroke
  9. PFO Study, MES Study
  10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
  11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
  12. Follow-up plan and 90 day mRS
Prospective post-implementation "standard of core care quality measures" cohort
  1. Extracranial imaging
  2. ECG in 2-7 days
  3. DVT prophylaxis
  4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
  5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
  6. Fasting lipid profile, HbA1c
  7. Holter monitor
  8. Specialized workup for young stroke
  9. PFO Study, MES Study
  10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
  11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
  12. Follow-up plan and 90 day mRS

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Post Core Measure Delivery
Tidsram: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 6 months
• Primary outcome measure will be successful implementation of the stroke care model as measured by survey done at the end assessing engagement and ability to continue the program in future and ability to implement the program across institutions. This will be measured by the NIHSS training, stroke education, awareness of core measures, the regularity of following the core measure and data collection.
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 6 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Modified Rankin Scale
Tidsram: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
Modified Rankin Scale is a 6 point disability scale from 0-6, and a greater score means worse outcome.
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
New ischemic stroke or Transient Ischemic Attack:
Tidsram: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
Hemorrhagic transformation:
Tidsram: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
Intracranial hemorrhage:
Tidsram: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
Death
Tidsram: From date of inclusion in the study until the date of discharge
From date of inclusion in the study until the date of discharge

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 januari 2021

Primärt slutförande (Faktisk)

30 juni 2021

Avslutad studie (Förväntat)

31 december 2021

Studieregistreringsdatum

Först inskickad

13 februari 2021

Först inskickad som uppfyllde QC-kriterierna

2 augusti 2021

Första postat (Faktisk)

6 augusti 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 augusti 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

2 augusti 2021

Senast verifierad

1 april 2021

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Clinical stroke extended management pathway

3
Prenumerera